Arama Sonuçları - A Geier

  • Gösterilen 1 - 11 sonuçlar arası kayıtlar. 11
Sonuçları Daraltın
  1. 1
    A case–control study of quadrivalent human papillomavirus vaccine-associated autoimmune adverse events

    A case–control study of quadrivalent human papillomavirus vaccine-associated autoimmune adverse events Yazar: David A. Geier, Mark R. Geier

    Baskı/Yayın Bilgisi 2014
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  2. 2
    Quadrivalent human papillomavirus vaccine and autoimmune adverse events: a case–control assessment of the vaccine adverse event reporting system (VAERS) database

    Quadrivalent human papillomavirus vaccine and autoimmune adverse events: a case–control assessment of the vaccine adverse event reporting system (VAERS) database Yazar: David A. Geier, Mark R. Geier

    Baskı/Yayın Bilgisi 2016
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  3. 3
    Respiratory conditions in coronavirus disease 2019 (COVID-19): Important considerations regarding novel treatment strategies to reduce mortality

    Respiratory conditions in coronavirus disease 2019 (COVID-19): Important considerations regarding novel treatment strategies to reduce mortality Yazar: Mark R. Geier, David A. Geier

    Baskı/Yayın Bilgisi 2020
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  4. 4
    A Comparison of the Autism Treatment Evaluation Checklist (ATEC) and the Childhood Autism Rating Scale (CARS) for the Quantitative Evaluation of Autism

    A Comparison of the Autism Treatment Evaluation Checklist (ATEC) and the Childhood Autism Rating Scale (CARS) for the Quantitative Evaluation of Autism Yazar: David A. Geier, Janet K. Kern, Mark R. Geier

    Baskı/Yayın Bilgisi 2013
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  5. 5
    Evidence of neurodegeneration in autism spectrum disorder

    Evidence of neurodegeneration in autism spectrum disorder Yazar: Janet K. Kern, David A. Geier, Lisa K. Sykes, Mark R. Geier

    Baskı/Yayın Bilgisi 2013
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  6. 6
    Relevance of Neuroinflammation and Encephalitis in Autism

    Relevance of Neuroinflammation and Encephalitis in Autism Yazar: Janet K. Kern, David A. Geier, Lisa K. Sykes, Mark R. Geier

    Baskı/Yayın Bilgisi 2016
    Tam Metin Erişim Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  7. 7
    A clinical trial of glutathione supplementation in autism spectrum disorders

    A clinical trial of glutathione supplementation in autism spectrum disorders Yazar: Janet K. Kern, David A. Geier, James B. Adams, Carolyn R. Garver, Tapan Audhya, Mark R. Geier

    Baskı/Yayın Bilgisi 2011
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  8. 8
    Immune dysfunction and neuroinflammation in autism spectrum disorder

    Immune dysfunction and neuroinflammation in autism spectrum disorder Yazar: Geir Bjørklund, Khaled Saad, Salvatore Chirumbolo, Janet K. Kern, David A. Geier, Mark R. Geier, Mauricio A. Urbina

    Baskı/Yayın Bilgisi 2016
    Tam Metin Erişim Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  9. 9
    A prospective double-blind, randomized clinical trial of levocarnitine to treat autism spectrum disorders

    A prospective double-blind, randomized clinical trial of levocarnitine to treat autism spectrum disorders Yazar: David A. Geier, Janet K. Kern, Georgia Davis, Paul King, James B. Adams, John L. Young, Mark R. Geier

    Baskı/Yayın Bilgisi 2011
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  10. 10
    Cerebral hypoperfusion in autism spectrum disorder

    Cerebral hypoperfusion in autism spectrum disorder Yazar: Geir Bjørklund, Janet K. Kern, Mauricio A. Urbina, Khaled Saad, Amira Elhoufey, David A. Geier, Salvatore Chirumbolo, Mark R. Geier, Jyutika Mehta, Jan Aaseth

    Baskı/Yayın Bilgisi 2018
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  11. 11
    Aktualisierte S2k-Leitlinie nicht-alkoholische Fettlebererkrankung der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – April 2022 – AWMF-Registernummer: 021–025

    Aktualisierte S2k-Leitlinie nicht-alkoholische Fettlebererkrankung der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – April 2022 – A... Yazar: Elke Roeb, Ali Canbay, Frank Tacke, Heike Bantel, Jörg Bojunga, Jan de Laffolie, Münevver Demir, U Denzer, A Geier, Wolf Peter Hofmann, Christian Hudert, Thomas Karlas, Marcin Krawczyk, Thomas Longerich, Tom Luedde, Michael Roden, Jörn M. Schattenberg, Martina Sterneck, Andrea Tannapfel, Patrick Lorenz

    Baskı/Yayın Bilgisi 2022
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:

Arama Araçları: